HER2 is involved in the regulation of cell growth, differentiation, and invasion and it is well known that its overexpression is associated with an aggressive phenotype and poor prognosis in breast cancer (BC) patients [1]. The gene discussed is ERBB2; the disease is breast carcinoma.